veopoz

Generic: pozelimab

Labeler: regeneron pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name veopoz
Generic Name pozelimab
Labeler regeneron pharmaceuticals, inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS SUBCUTANEOUS
Active Ingredients

pozelimab 200 mg/mL

Manufacturer
Regeneron Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 61755-014
Product ID 61755-014_a8be5cf0-49ba-4795-a2e5-7ea07f495958
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761339
Listing Expiration 2026-12-31
Marketing Start 2023-08-18

Pharmacologic Class

Established (EPC)
complement inhibitor [epc]
Mechanism of Action
complement inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 61755014
Hyphenated Format 61755-014

Supplemental Identifiers

RxCUI
2663945 2663952
UNII
0JJ21K6L2I
NUI
N0000175575 N0000175974

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name veopoz (source: ndc)
Generic Name pozelimab (source: ndc)
Application Number BLA761339 (source: ndc)
Routes
INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 200 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-014-01) / 2 mL in 1 VIAL, SINGLE-DOSE (61755-014-00)
source: ndc

Packages (1)

61755-014-01 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-014-01) / 2 mL in 1 VIAL, SINGLE-DOSE (61755-014-00)

Ingredients (1)

pozelimab (200 mg/mL)

Linked Drug Pages (1)

VEOPOZ ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "a8be5cf0-49ba-4795-a2e5-7ea07f495958", "openfda": {"nui": ["N0000175575", "N0000175974"], "unii": ["0JJ21K6L2I"], "rxcui": ["2663945", "2663952"], "spl_set_id": ["a8d6f10e-9430-450a-a3dd-b538f9b2a308"], "pharm_class_epc": ["Complement Inhibitor [EPC]"], "pharm_class_moa": ["Complement Inhibitors [MoA]"], "manufacturer_name": ["Regeneron Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61755-014-01)  / 2 mL in 1 VIAL, SINGLE-DOSE (61755-014-00)", "package_ndc": "61755-014-01", "marketing_start_date": "20230818"}], "brand_name": "VEOPOZ", "product_id": "61755-014_a8be5cf0-49ba-4795-a2e5-7ea07f495958", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Complement Inhibitor [EPC]", "Complement Inhibitors [MoA]"], "product_ndc": "61755-014", "generic_name": "Pozelimab", "labeler_name": "Regeneron Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VEOPOZ", "active_ingredients": [{"name": "POZELIMAB", "strength": "200 mg/mL"}], "application_number": "BLA761339", "marketing_category": "BLA", "marketing_start_date": "20230818", "listing_expiration_date": "20261231"}